Cargando…
Utilization of Stimuli-Responsive Biomaterials in the Formulation of Cancer Vaccines
Immunology research has focused on developing cancer vaccines to increase the number of tumor-specific effector cells and their ability to fight cancer over the last few decades. There is a lack of professional success in vaccines compared to checkpoint blockade and adoptive T-cell treatment. The va...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219237/ https://www.ncbi.nlm.nih.gov/pubmed/37233357 http://dx.doi.org/10.3390/jfb14050247 |